Korea’s Anti-corruption Agency Chief Reaffirms Government Stance Against Pharma Rebates; Doctors Will Be Prosecuted For Accepting Them
This article was originally published in PharmAsia News
Executive Summary
SEOUL - In a latest statement reaffirming the Korean government's bid against rebates among drug companies and doctors, the chief of the nation's anti-corruption agency warned that even doctors will be punished when they are found accepting rebates from pharma companies
You may also be interested in...
Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs
SEOUL - In the latest government action against irregular business deals in the medical sector, South Korea's Fair Trade Commission has imposed penalties amounting to KRW550 million (about $484,282) on the country's four leading general hospitals for receiving "donations" from 14 local and international pharmaceutical firms to fund expansion projects
Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs
SEOUL - In the latest government action against irregular business deals in the medical sector, South Korea's Fair Trade Commission has imposed penalties amounting to KRW550 million (about $484,282) on the country's four leading general hospitals for receiving "donations" from 14 local and international pharmaceutical firms to fund expansion projects
Middle East And North African Countries Represent New Growth Opportunities For Global Pharma Industry
After China and India, the Middle East and North African (MENA) regions could present another fast-growing opportunity for the global pharmaceutical industry. A recent launch of the first MENA-focused health fund by TVM Capital highlights the promise